The Hawaii Senate approved a bill that would create an advisory board to examine possible regulations for federal “breakthrough therapies” such as MDMA and psilocybin.
Rep. Adrian Tam (D), who previously passed through the House, has been amended by Senate Committees and passed the full chamber without any discussion. This was part of a package that included measures to the consent calendar on Tuesday. The House will now approve it.
The Aloha State has been discussing psychedelics reform this session. many proposals were brought up in committee by lawmakers and state agencies working to improve research on entheogenic substances.
Recently, the Senate passed Tuesday’s bill to make it mandatory, not permissive, for the state Department of Health to create the Breakthrough Therapy Designation Advisory Council. While the department supported the earlier version, which gave it the option for creating such a panel, it is unclear whether the mandate language will change its position on legislation.
DOH provided separate neutral testimony last month on other psychedelics policies proposals. A representative stated that DOH felt it would be “more meaningful” for lawmakers to simply allow substances like MDMA to prepare them for federal approval as medicines.
The DOH official stated that descheduling would enable medical professionals to “more freely discuss their experiences” within their practices and “the market will react.”
In written testimony supporting the legislation, the department reiterated its position last week before a Senate committee adopted the amendment mandating an advisory council.
It said that a community conversation is prudent for treatments that could have broader applications.
The Governor’s Office of the Wellness and Resilience supported the measure strongly.
It stated that “research on alternative therapies for treating mental health disorders has shown promising results.” It is important to create the space for this discussion in our state sooner than expected. This will help us make data-informed decisions about how and where we should focus our attention on complex social problems like mental health.
The office said that the Breakthrough Therapy Designation Advisory Council would provide a forum for these discussions so that new therapies can be reviewed quickly and relevant literature can be reviewed.
According to the bill, the legislature believes that state officials should be empowered to review applicable laws, regulations and studies whenever a breakthrough therapy designation has been issued. This will allow them to review any new treatment for mental health and substance abuse and prepare the State for its eventual approval by federal Food and Drug Administration.
Here’s HB1340 as amended:
A council of advisors would be established to examine federal and state regulations regarding certain psychedelics. They also will review scientific literature on their use for mental health treatment.
FDA breakthrough therapies would be evaluated by the council within three months after FDA has given that designation to the substance.
The OWR director, the state attorney general, the law enforcement director, legislative leadership, and a physician would be required to make up the members of the council. Other members could be appointed by the OWR director and top legislators.
The body would have to review the “requirements specifications and guidelines for a healthcare professional to prescribe and offer various treatments to patients who might benefit.”
The council must submit a report to the legislature within one year of its convening.
Marijuana Moment tracks more than 1000 cannabis, psychedelics, and drug policy bills in the state legislatures and Congress this yea. Patreon supporters who pledge at least $25 per month get access to our interactive maps and charts, as well as a hearing calendar so that they don’t miss any new developments.
Get access to our marijuana bill tracker by becoming a Patreon supporter.
—
Last month, Sen. Chris Lee (D), passed a Senate companion version and was referred to a House panel.
The House has rejected a bill from Hawaii to legalize marijuana. However, advocates are shifting their focus to 2024 and hope to pass the reform during the second half the two-year legislative session.
Sen. Joy San Buenaventura, D. , passed the Senate legislation last month. There were high hopes that it would make it to the House. A hearing was not scheduled prior to the deadline for bills that were referred to more than three committees. This means it will have to wait until next year in order to move forward.
Over several sessions, legislators have tried to legalize the Aloha State. However, the reform was passed in the Senate in 2021. However, after it failed to pass a House committee by the key deadline, it was halted.
Former Democratic governor Dave Ige was a difficult advocate. He said that he wasn’t willing to allow legalization because it would conflict with federal law. This is despite Hawaii’s medical marijuana system allowing people to grow and sale cannabis, in violation of broad federal prohibition.
Now that Gov. Actors are now feeling empowered by the swearing-in of Josh Green (D). In November, he said he would sign a bill to legalize marijuana for adults. He already has ideas on how tax revenue from cannabis sales could be used.
German Officials Reveal Revisionized Plan To Legalize Marijuana
Photo by Dick Culbert.
The post Hawaii Senate Approves a Bill To Create Psychedelics Advisory Council to Prepare For Federal Approval originally appeared on Marijuana Moment.
